Transient centrosome loss in cultured prostate epithelial cells induces chromosomal instability to produce an oncogenic genotype that correlates with poor clinical outcomes
Jiawen Yang, John M. RyniaweciD, Diogo de Oliveira PessôaiD, Matthew R. Coope, Daniel W. BusteriD, Emily Loertscher, Mengdie Wang, Chen Chen, Anne E. CressiD, Megha PadiiD, Gregory C. RogersiD
Abstract
Chromosomal instability (CIN) is a hallmark of prostate cancer that strongly correlates with metastatic burden and appears prominently in both primary cancer and metastatic disease. Low Gleason score primary prostate tumors display pervasive centrosome loss, a known mechanistic driver of CIN, that disrupts normal spindle assembly and increases mitotic errors. Previously, we found that transient depletion of centrosomes in immortalized, non-tumorigenic prostate epithelial cells (PrEC) induced a burst of CIN, generating cell lines capable of forming xenograft tumors. Here, we use a multi-omics approach to identify the oncogenic alterations caused by transient centrosome loss. By integrating genomic and transcriptomic data of the prostate lines, we identified a consensus set of focal copy-number variations (CNVs) induced by centrosome loss in cultured cells that are also detectable within a subset of samples from a prostate cancer patient cohort. Using this CNV signature, we were able to derive a unique transcriptomic signature from prostate cancer patient samples that showed strong predictive value for adverse clinical outcomes. In summary, our experimental system uses centrosome loss to promote a punctuated burst of genomic crisis that is characteristic of genome evolution during prostate cancer progression. Consequently, this prostate cancer model produced recurrent structural variations that are detectable in patient samples and associate with worse outcomes. Graphic Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/653266v1_ufig1.gif" ALT="Figure 1"> View larger version (55K): org.highwire.dtl.DTLVardef@ac4c9org.highwire.dtl.DTLVardef@fd9961org.highwire.dtl.DTLVardef@160e20corg.highwire.dtl.DTLVardef@198bf0e_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 10.19
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Somatic aberrations of BRCA1 gene are associated with progressive and stem cell-like phenotype of prostate cancer
Aleksandra Omari, Paulina Nastały, … Natalia Bednarz-Knoll·bioRxiv·Feb 26, 2018
- Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations with Race and Prostate Cancer Outcomes
Karen Sandell Sfanos, Rebecca Morton, … Angelo Michael De Marzo·Modern PathologyPeer-reviewed·Aug 12, 2026
- Transcriptional network analysis of PTEN protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication
Ivana Rondon‐Lorefice, Jose Ignacio Lopez, … Isabel Mendizabal·Molecular OncologyPeer-reviewed·Nov 17, 2025
- Increasing Cancer Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival
Xiaozhuo Liu, Anmbreen Jamroze, … Dean G. Tang·Molecular CancerPeer-reviewed·Oct 27, 2026
- Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1
Alvaro Gonzalo-Paulano, Alice Macchia, … V Torrano·bioRxiv·May 8, 2026
- The Telomere Length Landscape of Prostate Cancer
Julie M. Livingstone, Yu-Jia Shiah, … Paul Christopher Boutros·Nature CommunicationsPeer-reviewed·Nov 25, 2021